What's Next for Cremascoli Ortho?
Executive Summary
One of the few mid-sized European orthopedic companies to build a continental presence, Cremascoli has been extremely successful. But now it contemplates its future in an industry driven by consolidation.
You may also be interested in...
Stanmore: Creating a Specialty Orthopedics Company
Long a pioneer in prosthetics, one of orthopedics' forgotten spaces, Stanmore Implants Worldwide, has a new investor group who hope to transform this once academic supplier into a thriving orthopedics player by focusing on specialty niches that the Ortho giants have largely ignored.
Finding The Sweet Spot For Real-World Evidence: Aetion Stresses Early Feasibility Assessment
Robust natural history data sets with well-chosen outcomes are fundamental in Aetion’s regulatory feasibility tool for real-world evidence, built through analysis of US FDA case studies and guidance.